Zoxazolamine (BioDeep_00000001839)

   

human metabolite blood metabolite


代谢物信息卡片


5-chloro-2,3-dihydro-1,3-benzoxazol-2-imine

化学式: C7H5ClN2O (168.009039)
中文名称: 苯并恶唑胺
谱图信息: 最多检出来源 Homo sapiens(blood) 93.33%

分子结构信息

SMILES: C1=CC2=C(C=C1Cl)N=C(O2)N
InChI: InChI=1S/C7H5ClN2O/c8-4-1-2-6-5(3-4)10-7(9)11-6/h1-3H,(H2,9,10)

描述信息

D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents
C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant
C26170 - Protective Agent > C921 - Uricosuric Agent
D002491 - Central Nervous System Agents

同义名列表

2 个代谢物同义名

5-chloro-2,3-dihydro-1,3-benzoxazol-2-imine; Zoxazolamine



数据库引用编号

14 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Osbourne Quaye, Precious Cramer, Mark Ofosuhene, Laud K N Okine, Alexander K Nyarko. Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC. Journal of evidence-based complementary & alternative medicine. 2017 10; 22(4):753-759. doi: 10.1177/2156587217736587. [PMID: 29228815]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • Anjana G Vij, Krishna Kishore, Joginder Dey. Effect of intermittent hypobaric hypoxia on efficacy & clearance of drugs. The Indian journal of medical research. 2012; 135(?):211-6. doi: . [PMID: 22446863]
  • Junichiro Saito, Hiroko Fukushima, Hisamitsu Nagase. Anti-clastogenic effect of magnolol-containing Hange-koboku-to, Dai-joki-to, Goshaku-san, and Magnoliae Cortex on benzo(a)pyrene-induced clastogenicity in mice. Biological & pharmaceutical bulletin. 2009 Jul; 32(7):1209-14. doi: 10.1248/bpb.32.1209. [PMID: 19571387]
  • Junichiro Saito, Hiroko Fukushima, Hisamitsu Nagase. Inhibitory effect of magnolol on Trp-P-2-induced DNA damage in various organs in mice. Phytotherapy research : PTR. 2009 Jul; 23(7):901-5. doi: 10.1002/ptr.2748. [PMID: 19140158]
  • B K Chandan, A K Saxena, Sangeeta Shukla, Neelam Sharma, D K Gupta, K A Suri, Jyotsna Suri, M Bhadauria, B Singh. Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity. Journal of ethnopharmacology. 2007 May; 111(3):560-6. doi: 10.1016/j.jep.2007.01.008. [PMID: 17291700]
  • B Singh, B K Chandan, N Sharma, V Bhardwaj, N K Satti, V N Gupta, B D Gupta, K A Suri, O P Suri. Isolation, structure elucidation and in vivo hepatoprotective potential of trans-tetracos-15-enoic acid from Indigofera tinctoria Linn. Phytotherapy research : PTR. 2006 Oct; 20(10):831-9. doi: 10.1002/ptr.1856. [PMID: 16841368]
  • Hiroki Konishi, Kunihiko Morita, Tokuzo Minouchi, Akira Yamaji. Moricizine, an antiarrhythmic agent, as a potent inhibitor of hepatic microsomal CYP1A. Pharmacology. 2002 Dec; 66(4):190-8. doi: 10.1159/000065533. [PMID: 12393941]
  • B Singh, A K Saxena, B K Chandan, S G Agarwal, K K Anand. In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves. Indian journal of physiology and pharmacology. 2001 Oct; 45(4):435-41. doi: . [PMID: 11883149]
  • B Singh, A K Saxena, B K Chandan, V Bhardwaj, V N Gupta, O P Suri, S S Handa. Hepatoprotective activity of indigtone--a bioactive fraction from Indigofera tinctoria Linn. Phytotherapy research : PTR. 2001 Jun; 15(4):294-7. doi: 10.1002/ptr.760. [PMID: 11406850]
  • A K Nyarko, N A Ankrah, M Ofosuhene, A A Sittie. Acute and subchronic evaluation of Indigofera arrecta: absence of both toxicity and modulation of selected cytochrome P450 isozymes in ddY mice. Phytotherapy research : PTR. 1999 Dec; 13(8):686-8. doi: 10.1002/(sici)1099-1573(199912)13:8<686::aid-ptr519>3.0.co;2-b. [PMID: 10594940]
  • B H Ali, A K Bashir, M O Tanira. The effect of Rhazya stricta Decne, a traditional medicinal plant, on spontaneous and drug-induced alterations in activity of rats. Pharmacology, biochemistry, and behavior. 1999 Nov; 64(3):455-60. doi: 10.1016/s0091-3057(99)00099-4. [PMID: 10548255]
  • B G Procter, C I Chappel. Subchronic toxicity studies of sucrose acetate isobutyrate (SAIB) in the rat and dog. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 1998 Feb; 36(2):101-10. doi: 10.1016/s0278-6915(97)80301-8. [PMID: 9519848]
  • K K Anand, B Singh, A K Saxena, B K Chandan, V N Gupta, V Bhardwaj. 3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia belerica-bioassay guided activity. Pharmacological research. 1997 Oct; 36(4):315-21. doi: 10.1006/phrs.1997.0236. [PMID: 9425622]
  • P N Kourounakis, E Rekka. Effect of spironolactone on dimethyl mercury toxicity. A possible molecular mechanism. Arzneimittel-Forschung. 1994 Oct; 44(10):1150-3. doi: . [PMID: 7818591]
  • P M Vancutsem, J G Babish. Effects of ciprofloxacin and enrofloxacin on zoxazolamine kinetics, plasma concentration and sleeping times in mice. Toxicology letters. 1993 Jul; 69(1):1-14. doi: 10.1016/0378-4274(93)90139-o. [PMID: 8395094]
  • R W Nims, L E Beebe, K H Dragnev, P E Thomas, S D Fox, H J Issaq, C R Jones, R A Lubet. Induction of hepatic CYP1A in male F344/NCr rats by dietary exposure to Aroclor 1254: examination of immunochemical, RNA, catalytic, and pharmacokinetic endpoints. Environmental research. 1992 Dec; 59(2):447-66. doi: 10.1016/s0013-9351(05)80048-9. [PMID: 1281448]
  • T Ikeda, S Tsuda, Y Shirasu. Metabolic induction of the hepatic cytochrome P450 system by chlorfenvinphos in rats. Fundamental and applied toxicology : official journal of the Society of Toxicology. 1991 Aug; 17(2):361-7. doi: 10.1016/0272-0590(91)90225-s. [PMID: 1765223]
  • M Kukan, V Koprda, S Bezek, J Kálal, J Labský, T Trnovec. Disposition of lypophilized (methylmethacrylate-14C, 2-hydroxyethylmethacrylate, butylacrylate) nanoparticles in rats and their effect on zoxazolamine paralysis time. Die Pharmazie. 1991 Jan; 46(1):37-9. doi: . [PMID: 1857727]
  • M Yasuhara, G Levy. Pharmacodynamics of zoxazolamine and chlorzoxazone in rats. Pharmaceutical research. 1988 Jul; 5(7):401-7. doi: 10.1023/a:1015976131643. [PMID: 3247308]
  • M Yasuhara, G Levy. Kinetics of drug action in disease states. XXVII. Effect of experimental renal failure on the pharmacodynamics of zoxazolamine and chlorzoxazone. The Journal of pharmacology and experimental therapeutics. 1988 Jul; 246(1):165-9. doi: . [PMID: 3260625]
  • Z Damanhouri, M Gumbleton, P J Nicholls, M A Shaw. In-vivo effects of itraconazole on hepatic mixed-function oxidase. The Journal of antimicrobial chemotherapy. 1988 Feb; 21(2):187-94. doi: 10.1093/jac/21.2.187. [PMID: 2452150]
  • S Komthong, K Yoovathaworn, A Thithapandha. Biphasic effect of methadone on hepatic drug metabolism. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 1987 Jan; 184(1):40-6. doi: 10.3181/00379727-184-42443. [PMID: 3797427]
  • C O Abernathy, H J Zimmerman, R Utili. Effects of lipid A content, hydrocortisone and polymyxin B on endotoxin-induced decreases in in vivo drug metabolism. Microbios. 1987; 49(199):91-6. doi: ". [PMID: 3033452]
  • F R Puga, M A Rodrigues, M Doki. Effects of phenobarbital, chlordane, and oxytetracycline on DDT excretion in rats. Ecotoxicology and environmental safety. 1986 Dec; 12(3):261-6. doi: 10.1016/0147-6513(86)90017-5. [PMID: 3816644]
  • M Van der Graaff, N P Vermeulen, I E Crul, D D Breimer. Dose-dependent pharmacokinetics of zoxazolamine in the rat. Drug metabolism and disposition: the biological fate of chemicals. 1986 May; 14(3):331-5. doi: . [PMID: 2872034]
  • A W Wood, D S Smith, R L Chang, M T Huang, A H Conney. Effects of flavonoids on the metabolism of xenobiotics. Progress in clinical and biological research. 1986; 213(?):195-210. doi: ". [PMID: 3520588]
  • L Manara, P Coccia, T Croci. Prevention of TCDD toxicity in laboratory rodents by addition of charcoal or cholic acids to chow. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 1984 Oct; 22(10):815-8. doi: 10.1016/0278-6915(84)90120-0. [PMID: 6541620]
  • L K Griffeth, G M Rosen, E J Rauckman. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations. Drug metabolism and disposition: the biological fate of chemicals. 1984 Sep; 12(5):588-95. doi: . [PMID: 6149909]
  • L K Griffeth, G M Rosen, E J Rauckman. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine. Drug metabolism and disposition: the biological fate of chemicals. 1984 Sep; 12(5):582-7. doi: . [PMID: 6149908]
  • P Workman, P R Twentyman, F Y Lee, M I Walton. Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism. Biochemical pharmacology. 1983 Mar; 32(5):857-64. doi: 10.1016/0006-2952(83)90588-9. [PMID: 6838633]
  • A Parkinson, J Lasker, M J Kramer, M T Huang, P E Thomas, D E Ryan, L M Reik, R L Norman, W Levin, A H Conney. Effects of three recombinant human leukocyte interferons on drug metabolism in mice. Drug metabolism and disposition: the biological fate of chemicals. 1982 Nov; 10(6):579-85. doi: . [PMID: 6130903]
  • Y Masuda, N Nakayama. Protective effect of diethyldithiocarbamate and carbon disulfide against liver injury induced by various hepatotoxic agents. Biochemical pharmacology. 1982 Sep; 31(17):2713-25. doi: 10.1016/0006-2952(82)90124-1. [PMID: 6291543]
  • J M Lasker, Huang M-T, A H Conney. In vivo activation of zoxazolamine metabolism by flavone. Science (New York, N.Y.). 1982 Jun; 216(4553):1419-21. doi: 10.1126/science.7089530. [PMID: 7089530]
  • K G Jones, G D Sweeney. Dependence of the porphyrogenic effect of 2,3,7,8-tetrachlorodibenzo(p)dioxin upon inheritance of aryl hydrocarbon hydroxylase responsiveness. Toxicology and applied pharmacology. 1980 Mar; 53(1):42-9. doi: 10.1016/0041-008x(80)90379-8. [PMID: 7385237]
  • M Black, L Biempica, S Goldfischer, S Grossman, I M Arias. Effect of chronic renal failure in rats on structure and function of the hepatic endoplasmic reticulum. Experimental and molecular pathology. 1977 Dec; 27(3):377-91. doi: 10.1016/0014-4800(77)90008-9. [PMID: 923751]
  • H L Gurtoo, N B Parker. Sex-dependent regulation of benzo[a]pyrene and zoxazolamine metabolism in rat tissues. Drug metabolism and disposition: the biological fate of chemicals. 1977 Sep; 5(5):474-81. doi: NULL. [PMID: 20297]
  • B D Garg, P Kourounakis, B Tuchweber, S Szabo, K Kovacs. Studies on drug metabolism and liver ultrastructure after conjoint treatment with pregnenolone-16alpha-carbonitrile and dl-ethionine. Archives internationales de pharmacodynamie et de therapie. 1977 Jun; 227(2):283-93. doi: . [PMID: 907413]
  • P Kourounakis, H Selye. Actions of prednisolone acetate, pregnenolone-16alpha-carbonitrile, and triamcinolone upon drug resistance and metabolism: a comparative study. Canadian journal of physiology and pharmacology. 1977 Jun; 55(3):363-6. doi: 10.1139/y77-051. [PMID: 884592]
  • G M Fanelli. Urate excretion. Annual review of medicine. 1977; 28(?):349-54. doi: 10.1146/annurev.me.28.020177.002025. [PMID: 324366]
  • B Tuchweber, P Kourounakis, J G Latour. Drug metabolism and morphologic changes in the liver of nafenopin-treated rats. Archives internationales de pharmacodynamie et de therapie. 1976 Aug; 222(2):309-21. doi: . [PMID: 984981]
  • A Terzis, P Kourounakis, T Theophanides. Structural features and protective activity of dexamethasone and pregnenolone-16 alpha-carbonitrile. Journal of pharmaceutical sciences. 1976 Jul; 65(7):1092-4. doi: 10.1002/jps.2600650740. [PMID: 957124]
  • B Tuchweber, B D Garg, M Salas. Microsomal enzyme inducers and hypervitaminosis A in rats. Archives of pathology & laboratory medicine. 1976 Feb; 100(2):100-5. doi: . [PMID: 946392]
  • E S Reynolds, M T Moslen, S Szabo, R J Jaeger. Vinyl chloride-induced deactivation of cytochrome P-450 and other components of the liver mixed function oxidase system: an in vivo study. Research communications in chemical pathology and pharmacology. 1975 Dec; 12(4):685-94. doi: . [PMID: 175418]
  • P Warrick, A Rubin, C M Gruber. Interactions in rats between the nonsteroidal antiinflammatory drugs, aspirin and fenoprofen. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). 1974 Dec; 147(3):599-607. doi: 10.3181/00379727-147-38397. [PMID: 4445145]
  • Y Sakiya, S Awazu, M Hanano, H Nogami. [Pharmacokinetics on drug interaction: effect of zoxazolamine on the plasma concentration time course of chlorzoxazone]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 1974 Oct; 94(10):1307-11. doi: 10.1248/yakushi1947.94.10_1307. [PMID: 4477598]
  • H Selye, S Szabo, Y Taché, P Kourounakis, I Mécs I+MECS, J Taché J+TACHE. Effect of glucocorticoids upon resistance to various toxicants. Steroids and lipids research. 1974; 5(1):10-22. doi: NULL. [PMID: 4418494]
  • S Tanayama, S Momose, E Takagaki. Metabolism of 8-chloro-6-phenyl-4H-s-triazole(4,3-a)(1,4)benzodiazepine (D-40TA), a new central depressant. 3. Metabolism and tolerance studies in rats. Xenobiotica; the fate of foreign compounds in biological systems. 1974 Jan; 4(1):57-65. doi: 10.3109/00498257409052090. [PMID: 4826816]
  • P Kourounakis, S Szabo, H Selye. Effect of various steroids and ACTH on distribution of zoxazolamine in rats. Journal of pharmaceutical sciences. 1973 Dec; 62(12):1946-9. doi: 10.1002/jps.2600621208. [PMID: 4357627]
  • B Century. A role of the dietary lipid in the ability of phenobarbital to stimulate drug detoxification. The Journal of pharmacology and experimental therapeutics. 1973 May; 185(2):185-94. doi: ". [PMID: 4703818]
  • P Kourounakis, S Szabo, J Werringloer, H Selye. Effect of various steroids and ACTH on plasma levels of zoxazolamine and dicumarol. Journal of pharmaceutical sciences. 1973 Apr; 62(4):690-2. doi: 10.1002/jps.2600620437. [PMID: 4121532]
  • N Zöllner, W Gröbner. [Uricosuric agents]. Arzneimittel-Forschung. 1971 Oct; 21(10):1500-3. doi: NULL. [PMID: 5171869]
  • T C Westfall, D A Brase. Studies on the mechanism of tolerance to nicotine-induced elevations of urinary catecholamines. Biochemical pharmacology. 1971 Jul; 20(7):1627-35. doi: 10.1016/0006-2952(71)90291-7. [PMID: 5163092]
  • G M Fanelli, D L Bohn, S S Reilly. Renal effects of uricosuric agents in the chimpanzee. The Journal of pharmacology and experimental therapeutics. 1971 Jun; 177(3):591-9. doi: NULL. [PMID: 5568813]
  • A Breckenridge, M L Orme, S Thorgeirsson, D S Davies, R V Brooks. Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clinical science. 1971 Apr; 40(4):351-64. doi: 10.1042/cs0400351. [PMID: 5575281]
  • V G Prabhu, Y T Oester. Neuromuscular functions of mature mice following neonatal monosodium glutamate. Archives internationales de pharmacodynamie et de therapie. 1971 Jan; 189(1):59-71. doi: NULL. [PMID: 5130153]
  • G M Fanelli, D L Bohn, S S Reilly. Renal effects of uricosuric agents in the Cebus monkey. The Journal of pharmacology and experimental therapeutics. 1970 Nov; 175(2):259-66. doi: NULL. [PMID: 4991506]
  • C R Short, L E Davis. Perinatal development of drug-metabolizing enzyme activity in swine. The Journal of pharmacology and experimental therapeutics. 1970 Aug; 174(2):185-96. doi: NULL. [PMID: 5451356]
  • G C Becking, A B Morrison. Hepatic drug metabolism in zinc-deficient rats. Biochemical pharmacology. 1970 Mar; 19(3):895-902. doi: 10.1016/0006-2952(70)90252-2. [PMID: 5507694]
  • N Zöllner, W Gröbner. [The effect of coumarin, indandione and benzofuran derivatives on renal excretion of uric acid]. Deutsche medizinische Wochenschrift (1946). 1969 Dec; 94(51):2652-4. doi: NULL. [PMID: 4190226]
  • C Mitoma, L Lombrozo, S E LeValley, F Dehn. Nature of the effect of caffeine on the drug-metabolizing enzymes. Archives of biochemistry and biophysics. 1969 Nov; 134(2):434-41. doi: 10.1016/0003-9861(69)90303-8. [PMID: 5354771]
  • R Kato, A Takanaka, T Oshima. Effect of vitamin C deficiency on the metabolism of drugs and NADPH-linked electron transport system in liver microsomes. Japanese journal of pharmacology. 1969 Mar; 19(1):25-33. doi: 10.1254/jjp.19.25. [PMID: 4389559]
  • D Maroske, I M Weiner. The renal handling of zoxazolamine (flexin). The Journal of pharmacology and experimental therapeutics. 1968 Feb; 159(2):409-15. doi: NULL. [PMID: 5638660]
  • F E Greene, A E Wade. The relationship of hepatic drug metabolizing activity to serum esterase activities in the albino rabbits. Pharmacology. 1968; 1(6):363-8. doi: 10.1159/000135986. [PMID: 5710610]
  • R Kato, A Takanaka. Effect of starvation on the in vivo metabolism and effect of drugs in female and male rats. Japanese journal of pharmacology. 1967 Jun; 17(2):208-17. doi: 10.1254/jjp.17.208. [PMID: 4295244]
  • R Kato. Contrastic effects of ethionine and carbontetrachloride on ascorbic acid metabolism and on the activity of microsomal drug-metabolizing enzymes in rats. Japanese journal of pharmacology. 1967 Mar; 17(1):64-75. doi: 10.1254/jjp.17.64. [PMID: 5299976]
  • P Louyot. [The treatment of the kidney of the gouty patient]. Semaine therapeutique. 1964 Oct; 40(8):482-5. doi: NULL. [PMID: 5878572]
  • B TREADWELL. THE TREATMENT OF GOUT. The New Zealand medical journal. 1964 Sep; 63(?):567-74. doi: NULL. [PMID: 14210072]
  • P G DAYTON, P VRINDTEN, J M PEREL. STUDIES OF THE PROLONGED BIOCHEMICAL EFFECTS OF 3-METHYLCHOLANTHRENE AND OF ITS PHYSIOLOGICAL DISPOSITION IN THE RAT. Biochemical pharmacology. 1964 Feb; 13(?):143-52. doi: 10.1016/0006-2952(64)90131-5. [PMID: 14127293]
  • R RUFFIE, A FOURNIE. [TREATMENT OF GOUT]. Clinique (Paris, France). 1964 Jan; 59(?):7-11. doi: NULL. [PMID: 14133633]
  • N KUSU, Z TAKAGI. [DRUGS ACCELERATING EXCRETION OF URIC ACID]. [Sogo rinsho] Clinic all-round. 1963 Oct; 12(?):1976-85. doi: NULL. [PMID: 14092545]
  • A MUGLER. [EFFECT ON URICEMIA, URICOSURIA AND URIC ACID CLEARANCE OF THE ADMINISTRATION OF 2-ACETYLAMINO-5-CHLOROBENZOXAZOLE TO 47 GOUTY PATIENTS]. Revue du rhumatisme et des maladies osteo-articulaires. 1963 Jun; 30(?):363-9. doi: NULL. [PMID: 14070099]
  • J W POOLE, J F GARDOCKI. Prolongation of chlorzoxazone plasma levels by zoxazolamine. Journal of pharmaceutical sciences. 1963 May; 52(?):486-9. doi: 10.1002/jps.2600520520. [PMID: 13972181]
  • P H LAVIETES. Benemid, flexin and anturane as uricosuric agents. Connecticut medicine. 1962 Sep; 26(?):561-2. doi: NULL. [PMID: 14462935]
  • E B REED, T V FEICHTMEIR, S G CRAIG. Zoxazolamine as a uricosuric agent. I. Acute effects in healthy non-ghouty subjects. Arthritis and rheumatism. 1961 Oct; 4(?):533-51. doi: 10.1002/art.1780040509. [PMID: 14038637]
  • D B MONTGOMERY, M A OGRYZLO. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). Canadian Medical Association journal. 1960 Oct; 83(?):885-8. doi: NULL. [PMID: 13772195]
  • G RATTI, E CIRLA. [Observations on the uricosuric activity of zoxazolamine]. Reumatismo. 1959 Nov; 11(?):342-5. doi: NULL. [PMID: 14436447]
  • J M STREITZ. Nephrotoxicity associated with zoxazolamine administration. The New England journal of medicine. 1959 Jun; 260(25):1278-9. doi: 10.1056/nejm195906182602507. [PMID: 13666952]
  • E B REED, T V FEICHTMEIR, F M WILLETT. Zoxazolamine; a potent uricosuric agent; preliminary report. The New England journal of medicine. 1958 May; 258(18):894-6. doi: 10.1056/nejm195805012581808. [PMID: 13541682]
  • A A WEISS, G B D'ORONZIO, A EBEL. Evaluation of the effect of zoxazolamine (flexin) on spasticity. The Journal of urology. 1957 Sep; 78(3):294-300. doi: 10.1016/s0022-5347(17)66437-1. [PMID: 13464000]
  • T COHEN. Nephropathy associated with the oral administration of zoxazolamine (flexin); report of a case. The New England journal of medicine. 1957 Jun; 256(25):1193-4. doi: 10.1056/nejm195706202562508. [PMID: 13452021]